Buccal Versus Vaginal Misoprostol Combined with a Foley Catheter Among Individuals with Obesity Undergoing Induction.

Helen B Gomez SlagleTetsuya KawakitaMatthew K HoffmanAnthony SciscioneMarwan Ma'ayeh

Published in: American journal of perinatology (2024)

We found that vaginal misoprostol was superior to buccal misoprostol when combined with a FC among individuals with a BMI greater than or equal to 30 kg/m2. Therefore, vaginal misoprostol should be the preferred route of drug administration for term IOL in this population.

Keyphrases

drug administration
metabolic syndrome
weight gain
type diabetes
insulin resistance
weight loss
body mass index
preterm infants
skeletal muscle
gestational age
ultrasound guided